Safilo Group SpA (0NJ5.L)

Healthcare | Medical Instruments Supplies
Latest reporting period: 2026-04-07

Latest Quarter

2026-04-07

Revenue

$538M

Net Income

$41.7M

Operating Margin

9.5%

Free Cash Flow

$81.3M

Debt / Assets

46.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Safilo Group SpA (0NJ5.L).
Income Statement (Quarterly) 2026-04-07 2025-12-31 2025-06-30 2025-03-31
Revenue 537,626,000 445,753,000 537,626,000 268,813,000
Cost of Revenue 209,391,000 174,702,000 209,391,000 104,695,500
Gross Profit 328,235,000 271,051,000 328,235,000 164,117,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 284,768,000 272,265,000 284,768,000 142,384,000
Operating Expenses 276,959,000 272,265,000 276,959,000 138,479,500
Operating Income 51,276,000 -1,214,000 51,276,000 25,638,000
Interest Expense 0 0 0 0
Income Before Tax 51,479,000 15,480,000 51,479,000 25,739,500
Income Tax Expense 9,811,000 8,942,000 9,811,000 4,905,500
Net Income 41,710,000 7,362,000 41,710,000 20,855,000
Per Share
EPS 0.10 0.02 0.10 0.05
EPS Diluted 0.00 0.00 0.00 0.00